Literature DB >> 33683906

Epitope and Paratope Mapping by HDX-MS Combined with SPR Elucidates the Difference in Bactericidal Activity of Two Anti-NadA Monoclonal Antibodies.

Laura R Grauslund1,2, Valeria Calvaresi1,2, Werner Pansegrau2, Nathalie Norais2, Kasper D Rand1.   

Abstract

Characterization of antigen-antibody interactions is crucial for understanding antibody-mediated protection against pathogens, biopharmaceutical development, as well as evaluation of the immune response post vaccination. Bexsero is a multicomponent vaccine against Neisseria meningitidis serogroup B in which one of the key vaccine antigens is Neisserial adhesin A (NadA), a trimeric coiled-coil protein. Two NadA-specific monoclonal antibodies (mAbs) isolated from Bexsero-vaccinated individuals have been shown to have similar binding affinity and appear to recognize a similar antigen region, yet only one of the mAbs is bactericidal. In this study, we use hydrogen/deuterium exchange mass spectrometry (HDX-MS) to perform an in-depth study of the interaction of the two mAbs with NadA antigen using a combined epitope and paratope mapping strategy. In addition, we use surface plasmon resonance (SPR) to investigate the stoichiometry of the binding of the two mAbs to NadA. While epitope mapping only identifies a clear binding impact of one of the mAbs on NadA, the paratope mapping analyses shows that both mAbs are binding to NadA through several complementarity determining regions spanning both heavy and light chains. Our results highlight the advantage of combined epitope and paratope mapping HDX-MS experiments and supporting biochemical experiments to characterize antigen-antibody interactions. Through this combined approach, we provide a rationale for how the binding stoichiometry of the two mAbs to the trimeric NadA antigen can explain the difference in bactericidal activity of the two mAbs.

Entities:  

Keywords:  HDX-MS; NadA; binding stoichiometry; epitope mapping; paratope mapping

Mesh:

Substances:

Year:  2021        PMID: 33683906     DOI: 10.1021/jasms.0c00431

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  5 in total

Review 1.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

Review 2.  Computational Structure Prediction for Antibody-Antigen Complexes From Hydrogen-Deuterium Exchange Mass Spectrometry: Challenges and Outlook.

Authors:  Minh H Tran; Clara T Schoeder; Kevin L Schey; Jens Meiler
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIX.

Authors:  Joey G Sheff; John F Kelly; Anna Robotham; Traian Sulea; Félix Malenfant; Denis L'Abbé; Mélanie Duchesne; Alex Pelletier; Jean Lefebvre; Andrea Acel; Marie Parat; Mylene Gosselin; Cunle Wu; Yves Fortin; Jason Baardsnes; Henk Van Faassen; Shannon Awrey; Shawn C Chafe; Paul C McDonald; Shoukat Dedhar; Anne E G Lenferink
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

4.  Hydrogen-Deuterium Exchange Mass Spectrometry Reveals a Novel Binding Region of a Neutralizing Fully Human Monoclonal Antibody to Anthrax Protective Antigen.

Authors:  Mulin Fang; Zhe Wang; Kathleen Norris; Judith A James; Si Wu; Kenneth Smith
Journal:  Toxins (Basel)       Date:  2022-01-25       Impact factor: 5.075

5.  Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.

Authors:  Esmaeil Dorraji; Elin Borgen; Dario Segura-Peña; Puneet Rawat; Eva Smorodina; Claire Dunn; Victor Greiff; Nikolina Sekulić; Hege Russnes; Jon Amund Kyte
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.